ICH GCP Goes Risk-Based

by Artem Andrianov, PhD, Beat Widler, PhD, Maria Proupín-Pérez, PhD

Originally published by Applied Clinical Trials Online

ICH GCP goes Risk-based 2


Available: http://www.appliedclinicaltrialsonline.com/ich-gcp-goes-risk-based.


By |2016-11-16T18:35:42+00:00October 21, 2015|News|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment

Upcoming Events

  1. DIA Europe 2019

    February 5 - February 7

Register Today!

Get Free Test Access